Comparative study of Korean White Ginseng and Korean Red Ginseng on efficacies of OVA-induced asthma model in mice  by Lim, Chi-Yeon et al.
lable at ScienceDirect
J Ginseng Res 39 (2015) 38e45Contents lists avaiJournal of Ginseng Research
journal homepage: http: / /www.ginsengres.orgResearch articleComparative study of Korean White Ginseng and Korean Red Ginseng
on efﬁcacies of OVA-induced asthma model in mice
Chi-Yeon Lim 1,q, Jeong-Min Moon 2,q, Bu-Yeo Kim 3, Se-Hyun Lim 4, Guem-San Lee 5,
Hak-Sun Yu 6, Su-In Cho 2,*
1College of Medicine, Dongguk University, Ilsan, Gyeonggi-do, Korea
2 School of Korean Medicine, Pusan National University, Yangsan, Korea
3Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon, Korea
4 School of Public Health, Far East University, Chungbuk, Korea
5College of Korean Medicine, Wonkwang University, Iksan, Jeonbuk, Korea
6Department of Parasitology, School of Medicine, Pusan National University, Yangsan, Koreaa r t i c l e i n f o
Article history:
Received 23 April 2014
Received in Revised form
22 July 2014
Accepted 25 July 2014





white ginseng* Corresponding author. School of Korean Medicine
E-mail address: sicho@pusan.ac.kr (S.-I. Cho).
This is an Open Access article distributed under the t
which permits unrestricted non-commercial use, dist
q
Chi-Yeon Lim and Jeong-Min Moon equally contr
1226-8453/$ e see front matter Copyright  2014, Th
http://dx.doi.org/10.1016/j.jgr.2014.07.004a b s t r a c t
Background: Korean ginseng is a well-known medicinal herb that has been widely used in traditional
medicine to treat various diseases, including asthma. Ginseng can be classiﬁed as white ginseng (WG) or
red ginseng (RG), according to processing conditions. In this study, the authors compared the efﬁcacies of
these two ginseng types in a mouse model of acute asthma.
Methods: To produce the acute asthma model, BALB/c mice were sensitized with ovalbumin (OVA) and
aluminum hydroxide, and then challenged with OVA. WG and RG extracts were administered to mice
orally. The inﬂuences of WG and RG on airway hyperresponsiveness (AHR), immune cell distributions in
bronchoalveolar lavage ﬂuid (BALF), and OVA-speciﬁc immunoglobulin E (IgE), IgG1, and IgG2a in serum
were investigated. Cytokine production by lymphocytes isolated from peribronchial lymph nodes and
histopathological changes was also examined.
Results: In OVA-sensitized mice, both WG and RG reduced AHR and suppressed immune cell inﬁltration
in bronchoalveolar regions. BALF OVA-speciﬁc IgE levels were signiﬁcantly lower in RG-treated OVA-
sensitized mice than in the OVA-sensitized control group. WG and RG also suppressed inﬂammatory
cytokine production by peribronchial lymphocytes. Histopathological ﬁndings showed reduced inﬂam-
matory cell inﬁltration and airway remodeling (e.g., epithelial hyperplasia) in WG- and RG-treated OVA
mice compared with OVA controls.
Conclusion: In this study, WG and RG showed antiasthmatic effects in an OVA-sensitized mouse model,
and the efﬁcacies of RG were found to be better than those of WG.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Korean ginseng, the root of Panax ginseng Meyer, is one of the
most popular medicinal herbs in traditional Koreanmedicine and is
also extensively used worldwide to treat various diseases by herbal
medicine practitioners [1]. P. ginseng has been used as a general
tonic for the promotion of health in Asian countries, and its phar-
macological properties have been attributed to its ginsenoside, Pusan National University, Beom
erms of the Creative Commons At
ribution, and reproduction in any
ibuted to this work.
e Korean Society of Ginseng, Publcomponents [2]. Many bioactive constituents are present in ginseng
extracts, and ginsenosides, the main constituents of ginseng, are
believed to have antiallergic, antioxidant, and immune-stimulatory
activities [3].
The two traditional preparations of Korean ginseng, white
ginseng (WG) and red ginseng (RG), are presumed to have different
bioactivities in traditional medicine. WG is produced by the sun
drying of fresh ginseng, whereas RG is manufactured by steamingeo-ri, Mulgeum-eup, Yangsan City, Gyeongnam 626-870, Korea.
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Many researchers have reported that the steaming process increases
the bioactivity of ginseng [4e6]. Few comparative studies have been
conducted on the effects of WG and RG on various diseases.
Asthma is a serious health problem and affects people of all ages,
and its most common trigger is continuous exposure to allergens
[7]. Allergic asthma is characterized by increased mucus produc-
tion, reversible airway obstruction, eosinophil inﬁltration, and
nonspeciﬁc airway hyperresponsiveness (AHR) [8]. The develop-
ment of asthma is mediated by the overexpression of T helper
type 2 (Th2)-mediated or Th1-mediated cytokines, such as inter-
leukin (IL)-4, IL-5, etc. [8,9]. However, currently available therapies
cannot completely control the symptoms of asthma, and even
intensive treatment shows little effect on healthcare utilization
[10]. Consequently, efforts are required to identify new remedies,
preferably of natural origin, for mitigating the effects of these im-
mune-related disorders.
P. ginseng is one of most commonly used medicinal herbs to
complement the treatment of asthma, allergies, and immunologic
conditions [11]. Several researchers have reported that P. ginseng
ameliorates asthma in animal models [12,13], but to date, the ef-
fects of processing on its medicinal effects have not been studied.
Therefore, in the present study, we compared the effects of WG
and RG in a mouse model of acute asthma. In previous studies we
reported that herbal remedies offer potential complementary or
alternative treatments and showed that the regulation of Th1/Th2
balance could provide a strategy for the treatment of respiratory
diseases [14,15].
In this study, we investigated the effects of WG and RG on the
inﬁltration of inﬂammatory cells, on airway remodeling, and on
expressions of inﬂammation-related cytokines in an ovalbumin
(OVA)-sensitized mouse model of acute asthma.
2. Materials and methods
2.1. Animals
Seven-week-old female BALB/cmice (DaehanBiolink, Chungbuk,
Korea) were housed in polypropylene cages at 24 4C under a 12 h
light anddark cycle for at least 1week prior to experiments. Animals
were fed with a standard pellet diet and supplied water ad libitum.
All experiments were approved by the Institutional Animal CareFig. 1. High performance thin layer chromatography (HPTLC) images of the ﬁngerprints of w
on HPTLC plates (silica gel F254; chloroform/methanol, 7:3; under UV or white light) and d
Under 254 nm UV light. (B) Under 366 nm UV light. (C) Under 366 nm UV light after spra
Numbers on plates are Rf values. Arrows indicate speciﬁc components of WG or RG.Committee of Pusan National University and conducted in accor-
dance with the guidelines issued by Pusan National University.
2.2. Preparation of ginseng extracts and reagents
Standardized 5-yr-old Korean WG and RG were purchased from
Gwangmyung Natural Pharmaceutical Co. (Busan, Korea); voucher
specimens (No. 201KWG and 201KRG) were deposited at the Her-
barium of the School of Korean Medicine, Pusan National Univer-
sity. WG and RG (1 kg) were ﬁnely ground and extracted with 10
times their volumes of 80% methanol at room temperature for 3 d
and then the extraction process was repeated three times. After
ﬁltration using ﬁlter paper (Advantec, Tokyo, Japan), methanol was
removed using a vacuum evaporator (Eyela, Tokyo, Japan) at 45C,
and the resulting extracts (WG and RG) were stored at 20C until
required. OVA (Grade V) was purchased from Sigma-Aldrich (St.
Louis, MO, USA). Before use, OVA was detoxiﬁed using a DetoxiGel
column (Pierce, Rockford, IL, USA).
2.3. High performance thin layer chromatography analysis for WG
and RG ﬁngerprinting
For quality assurance purposes, each extract was subjected to
high performance thin layer chromatography (HPTLC). Chloroform
andmethanol (7:3, v/v)wereused as the developer solvents, and the
bands that developed on HPTLC plates were detected using a Camag
visualizer (Camag, Sonnenmattstrasse, Muttenz, Switzerland). It
was found that compounds were altered by the steaming process,
which suggests this is responsible for their different bioactivities.
Fig. 1A lists compounds found in WG and Figs. 1Be1D list com-
pounds found in RG.
2.4. Induction of asthma and the experimental animal groups
The experimental protocols employed were as described in our
previous report [14]. Brieﬂy, 200 mL of phosphate buffer saline (PBS)
or emulsion containing 100 mg of OVA and 2 mg of aluminum hy-
droxide was injected into the mouse intraperitoneally (i.p.) on Day
1 and Day 14. On Day 22, mice were anesthetized with ketamine
(100 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.), and on Days 22, 23,
and 24 received 30 mL of PBS containing 25 g of OVA by intranasal
instillation. WG and RG extracts were administration for 10hite ginseng (WG) and of red ginseng (RG). WG (a) and RG (b) extracts were developed
ocumented using a visualizer (Camag, Sonnenmattstrasse, Muttenz, Switzerland). (A)
ying with p-anisaldehyde. (D) Under white light after spraying with p-anisaldehyde.
Fig. 2. Experimental design and the acute asthma model. Control, white ginseng (WG),
and red ginseng (RG) groups were sensitized intraperitoneally on Days 1 and 14, and
challenged intranasally on Days 22, 23, and 24. Animals were administered WG or RG
from Days 15 to 24. All animals were sacriﬁced on Day 26. I.N., intranasal; I.P., intraper-
itoneal;MBPT, methacholine bronchial provocation test; PHS, phosphate buffered saline.
J Ginseng Res 2015;39:38e4540consecutive days between 9:00 AM and noon from Day 15 to Day 24
(Fig. 2).
The experimental groups were as follows: (1) naïve: OVA-
sensitized but not challenged and administered PBS; (2) control:
sensitized and challenged with OVA and administered PBS; and (3)
WG or RG: sensitized and challenged with OVA and administered
WG or RG, respectively.
2.5. Treatment with WG or RG extracts
Seven-week-old male BALB/c mice were randomly divided into
eight groups: 30, 90, and 300 mg/kg WG-treated, 30, 90, and 300
RG-treated, PBS-treated control and the treatment naïve group.
Each group consisted of nine mice. In Korean traditional medicine,
30 mg/kg is the recommended daily dose for WG and for RG. Each
concentration of WG or RG in PBS was administered by oral intu-
bation for 10 d. Animals in the naïve and PBS-treated control groups
were given the same volume of PBS by oral intubation. At the end of
treatment, animals were sacriﬁced and the following samples were
collected for analysis; bronchoalveolar lavage ﬂuid (BALF), blood,
and lung and bronchial lymph nodes.
2.6. Measurement of AHR
Airway responsiveness to methacholine was measured using a
whole body plethysmograph (OCP 3000, Allmedicus, Gyounggi,
Korea), which provides a noninvasive measure of airway respon-
siveness in mice [16]. One day after the last OVA challenge via nasal
inhalation (Day 25), mice were exposed to increasing doses of
methacholine using an ultrasonic nebulizer (Pari, Starnberg,
Germany) for 150 s at each concentration. AHR was calculated in
enhanced pause (Penh) aswe previously described [14]. The formula
used was as follows: Penh ¼ (Te/RT-1)  PEF/PIF, where
Te ¼ expiration time (s), RT ¼ relaxation time (s), REF ¼ peak expi-
ratory ﬂow rate (mL/s) and IF ¼ peak inspiratory ﬂow rate (mL/s).
2.7. Analysis of BALF
On Day 26, to obtain BALF, mice were sacriﬁced with a lethal
dose of ketamine and xylazine, and BALF was collected from tra-
cheas; 1.8 mL of PBS was introduced to the lungs, and more than
1.5 mL of buffer was consistently retrieved. BALF cells were
analyzed as previously described [17]. Brieﬂy, differential cell
counts were performed by counting cytospin preparations stained
with Diff-Quick (Dade Behring, Düdingen, Switzerland).
2.8. Determination of serum antibody concentrations
Micewere bled on Day 26, and blood samples were stored at 4C
overnight and then centrifuged at 2,800  g for 10 min to obtainsera. OVA-speciﬁc immunoglobulin (IgE, IgG1 and IgG2a) levels in
serum were measured by ELISA, according to the manufacturer’s
instructions (BD Pharmingen, San Jose, CA, USA).
2.9. Cytokine detection in peribronchial lymphocytes
Levels of cytokine production by peribronchial lymphocytes
were measured as previously described [18]. Brieﬂy, on Day 26,
peribronchial lymph nodes were isolated and prepared as single
cell suspensions. Cells (2  105 cells/mL) were then plated on 96-
well microplates and cultured for 3 d with OVA (50 mg/mL) in
200 mL RPMI-1640 medium containing 10% fetal bovine serum
(FBS). Supernatants were analyzed for IL-4, IL-5, IL-6, transforming
growth factor beta (TGF-b) (BD Pharmingen), and IL-13 (R&D Sys-
tems, Minneapolis, MN, USA) by ELISA, according to the manufac-
turer’s instructions. OVA-speciﬁc cytokine levels were then
calculated.
2.10. Lung histology
On Day 26, after obtaining BALF, the lungs and tracheas were
resected and ﬁxed overnight in 4% formalin. Specimens were then
dehydrated in an alcohol series, embedded in parafﬁn wax, and
sectioned at 5 mm. Sectionswere placed on glass slides, stainedwith
hematoxylin and eosin, and examined under a light microscope.
2.11. Statistical analysis
Results are expressed asmean standard deviation (SD), and all
statistical comparisons were performed by one-way analysis of
variance followed by Duncan’s multiple comparison test. SPSS
version 18 (SPSS Inc., Chicago, IL, USA) was used for statistical
analysis. Statistical signiﬁcance was accepted for p values < 0.05.
3. Results
3.1. Effects of WG or RG on numbers of inﬂammatory cells in BALF
Inﬂammatory cells were signiﬁcantly increased in BALF in the
PBS-treated control group (OVA þ Alum), but treatment with WG
or RG signiﬁcantly decreased total cells including macrophages and
other inﬂammation-related immune cells (Fig. 3). Eosinophilic
inﬂammation is a hallmark of asthma, and RG treatment remark-
ably decreased BALF eosinophils in dose-dependent manner in the
RG-treated group as compared with the PBS-treated control group.
3.2. Effects of WG or RG on airway responsiveness to methacholine
We examined AHR bymethacholine inhalation. AHR resistances
were measured as Penh values on Day 25 after methacholine
inhalation. AHR in the PBS-treated control group was signiﬁcantly
increased as compared with that of the naïve group (Fig. 4). After
exposure to 50 mg/mL of methacholine, Penh in the control group
was increased by 443% versus the naïve group (10.05  3.35 vs.
2.27  0.72). In the WG- or RG-treated groups, Penh values were
decreased by 21.59% and 35.92%, respectively, versus the control
group (2.17  0.76 vs. 10.05  3.35 and 3.61 1.13 vs. 10.05  3.35,
respectively) (Figs. 4A and 4B).
3.3. Effects of WG and RG on OVA-speciﬁc IgE, IgG1, and IgG2a in
serum
Marked increases in the levels of OVA-speciﬁc IgE were
observed in the control group (Fig. 5). The WG and RG groups
showed lower levels of IgE, and RG was more effective than WG.
Fig. 4. Effects of white ginseng (WG) and red ginseng (RG) on airway hyperresponsiveness. Results are presented as mean  SD. #p < 0.05 vs. the naïve group; *p < 0.05 vs. the
phosphate buffer saline (PBS)-treated control group; **p < 0.01 vs. the PBS-treated control group; ***p < 0.001 vs. the PBS-treated control group. Alum, aluminum hydroxide; ns, not
speciﬁc; OVA, ovalbumin; Penh, enhanced pause.
Fig. 5. Effect of white ginseng (WG) and red ginseng (RG) on serum immunoglobulin E
(IgE). Samples of serum were collected on Day 26, and levels of ovalbumin (OVA)-
speciﬁc serum IgE were measured. Results are presented as means  SD. #p < 0.05 vs.
the naïve group; *p < 0.05 vs. the phosphate buffer saline (PBS)-treated control group;
**p < 0.01 vs. the PBS-treated control group; xp < 0.05 vs. the WG group.
Fig. 3. Effects of white ginseng (WG) and red ginseng (RG) on total and differential cell counts in bronchoalveolar ﬂuid (BALF). Results are presented as mean  SD. #p < 0.05 vs. the
naïve group; *p < 0.05 vs. the phosphate buffer saline (PBS)-treated control group. Eos, eosinophils; Lym, lymphocytes; Mac, macrophages; Neu, neutrophils.
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observed in the control group as compared with the naïve group.
However, treatment with WG or RG did not affect OVA-speciﬁc
IgG1 and IgG2a production in serum (Figs. 6Ae6D).
3.4. Effects of WG and RG on lung histopathology
In the naïve group, few inﬂammatory cells appeared around
respiratory tracts, blood vessels, or alveolar spaces, and no histo-
pathological changes such as mucosal thickening were observed
(Fig. 7A). However, in the PBS-treated control group, obvious in-
ﬁltrations of inﬂammatory cells were observed in connective tis-
sues (Fig. 7B). Such changes appeared even though alveolar spaces
had been washed once with PBS to obtain BAL ﬂuid. Furthermore,
marked mucosal thickening was also observed. In the WG- and RG-
treated groups, inﬂammatory cell inﬁltration and mucosal thick-
ening were less severe than in the PBS-treated control group
(Figs. 7Ce7H). In the RG group, inﬂammatory cell inﬁltration and
mucosal thickening were less severe than in the WG group.
3.5. Effects of WG or RG on cytokine production by peribronchial
lymphocytes
The cytokine proﬁles of peribronchial lymph node cells were
analyzed via in vitro OVA stimulation. High levels of IL-4, IL-5, IL-6,
and IL-13 production conﬁrmed the Th2 nature of the
Fig. 6. Effects of white ginseng (WG) and red ginseng (RG) on serum IgG1 and IgG2. Samples of serumwere collected on Day 26, and levels of ovalbumin (OVA)-speciﬁc serum IgG1
and IgG2a were measured.
J Ginseng Res 2015;39:38e4542inﬂammatory response in OVA-induced asthma (Fig. 8), although
TGF-b production was not changed (data not shown). The WG and
RG groups of mice showed low levels of cytokine production, and
RG was more effective than WG at regulating cytokine production
in peribronchial lymphocytes based on statistical analysis between
same dosage WG and RG groups (Fig. 8).
4. Discussion
P. ginseng, also called Korean ginseng, is one of the most widely
used functional health foods for revitalization and eliminating
chronic fatigue, and has been used as a dietary supplement in Asia
for > 2000 yr [19]. P. ginseng, both red and white preparations, is
most commonly used in traditional Korean medicine, but there
are some differences between them, such as in their ginsenoside
contents and pharmacological effects. RG is manufactured when
WG is produced by additional steaming and sun drying [4], and
during this process, ginsenosides undergo chemical changes
that could increase physiologic activities [19]. Currently, > 30
different ginsenosides have been isolated and characterized from
P. ginseng, and these ginsenosides are known to have different
pharmacologic effects [19]. However, the comparative studies of
WG and RG on various diseases have not been sufﬁciently
investigated.
Asthma is a serious, worldwide public health problem that af-
fects all ages. It is an inﬂammatory disease of the airways that can
be exacerbated by numerous extrinsic factors, such as continuous
exposure to allergens [7]. However, the pathophysiological mech-
anism of asthma is unclear despite the increasing prevalence of thisdisease. Furthermore, current therapies fail to provide an adequate
therapeutic solution.
Currently, corticosteroids are the drugs most commonly used to
control airway inﬂammation, however, corticosteroid therapy has
important adverse effects, and some patients are completely
corticoid resistant or fail to show clinical improvement after high
dose glucocorticoids treatment [20]. Therefore, the development of
safer, more effective antiasthmatic drugs is required, and evalua-
tion of the potential bioactivities of new compounds with unique
mechanisms of action remains an important topic of research [20].
Consequently, efforts should bemade to identify newantiasthmatic
remedies, preferably of natural origin, to mitigate the effects of
asthma.
Kim and Yang [12] reported that P. ginseng treatment restores
the expression of several genes including EMBP, Muc5ac, and CD40,
and the mRNA and protein levels of IL-1b, IL-4, IL-5, and tumor
necrosis factor (TNF)-a, but no description was provided of in-
ﬂammatory cell counts and IgE production in asthmatic mice,
which probably underlie the mechanism of asthma. Furthermore,
the effects of ginseng on asthma have received little attention. For
this reason, we examined and compared the effects of WG and RG
in an asthmatic mouse model.
Eosinophils are important immune cells and contribute to the
development of allergic and asthmatic inﬂammation, to the
inﬁltration of eosinophils into airways, and the release of their
contents has been linked to symptom severity in asthma [21]. In
the present study, eosinophils were absent in the BALF of the
naïve group of mice and markedly increased in the PBS-treated
control group (Fig. 3). Other inﬂammatory cells were also
Fig. 7. Effect of white ginseng (WG) and red ginseng (RG) on bronchoalveolar inﬂammation. Light microscopy revealed abnormal respiratory epithelium (ellipsoid area), and high
numbers of inﬁltrated inﬂammatory cells (arrows) in the phosphate buffer saline (PBS)-treated control group as compared with the naïve group. (A) Treatment naïve group. (B) PBS-
treated control group. (CeE) WG-treated groups (treated with 30, 90, and 300 mg/kg/d, respectively). (FeH) RG-treated groups (treated with 30, 90, and 300 mg/kg/d, respectively).
Photomicrographs of axial sections of mouse lungs ( 100, H&E stain).
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administration effectively suppressed eosinophil inﬁltration into
lung bronchioles. Fig. 7 shows the marked inﬁltrations of in-
ﬂammatory cells, including eosinophils, neutrophils, and lym-
phocytes, observed in connective tissues not only around large
vessels and airways but also around small vessels and airways in
the control group. Although alveolar spaces were washed once
with PBS to obtain BALF, many inﬁltrated inﬂammatory cells
remained. However, in the WG and RG groups, inﬂammatory cell
inﬁltrations were much reduced as compared with the control
group. In addition, mucosal thickening was frequently observed
in the control group (Fig. 7B), but in the WG and RG groups,
mucosal thickening was moderately reduced, and RG seemed to
be more effective than WG.
AHR is a particular feature of asthma and leads to recurrent
episodes of shortness of breath, wheezing, and coughing [22]. In
the present study, we observed AHR changes by methacholine
challenge testing. WG and RG inhibited AHR as evidence by re-
ductions in Penh values to levels similar to those observed in the
naïve group (Fig. 4).
Asthma is associated with IgE production, for example, recent
studies on the effects of anti-IgE therapy have conﬁrmed that IgE
plays an important role in asthma [23,24]. Balza et al [24] reported a
positive relationship between airway IgE expression and serum IgE
levels. In the present study, the expression of IgE in serum was
markedly higher in the PBS-treated control group than in the naïve
group, but WG or RG administration signiﬁcantly decreased IgE
serum level (Fig. 5), and RG was more effective than WG. However,neither WG nor RG inﬂuenced IgG1 and IgG2a serum levels in
asthmatic mice (Fig. 6).
Th2 cell-associated inﬂammation is considered as an impor-
tant mediator of asthma, and Th2-type cytokines, such as IL-4,
IL-5, and IL-13, are thought to drive the disease pathology [25].
Moreover, there is strong evidence that the Th2-cytokine pattern
plays an important role in the pathogenesis of asthma via the
release of IL-4, IL-5, and IL-13 [26]. Accordingly, we analyzed the
cytokine proﬁles of bronchial lymph node cells after in vitro OVA
stimulation. High levels of IL-4, IL-5, IL-6, and IL-13 production
conﬁrmed the Th2 nature of the inﬂammatory response in the
PBS treated control group (Fig. 8). Furthermore, cytokine pro-
duction by lymphocytes in the WG and RG groups was signiﬁ-
cantly lower than in the control group, and RG was again more
effective than WG.
5. Conclusions
WG and RG effectively suppressed inﬂammatory cell inﬁltra-
tion into bronchoalveolar regions. AHR and airway remodeling in
OVA-induced asthma were also ameliorated by WG and RG. The
study shows that WG and RG regulate serum IgE levels, which is an
important biomarker of asthma. In addition, WG and RG signiﬁ-
cantly suppressed pro-inﬂammatory cytokine production by per-
ibronchial lymphocytes. Furthermore, RG was more potent than
WG in all respects. However, as most medicinal herbs have mul-
tiple components, it is unclear which component plays key roles
in the above-mentioned activities. Therefore, further studies are
Fig. 8. Comparisons of ovalbumin (OVA)-speciﬁc cytokine production of peribronchial lymph node cells. Lymph nodes of mice were collected on Day 26, and after 3 d of incubation
with OVA, OVA-speciﬁc pro-inﬂammatory cytokine levels in cell culture media were measured. Results are presented as mean  SD. #p < 0.05 vs. the naïve group; *p < 0.05 vs. the
PBS-treated control group; **p < 0.01 vs. the PBS-treated control group; xp < 0.05 vs. the WG group.
J Ginseng Res 2015;39:38e4544needed to identify the key molecules underlying these effects and
efﬁcacies.
Conﬂicts of interest
The authors have no potential conﬂict of interest to declare. The
authors alone are responsible for the writing of this paper.
Acknowledgments
This work was supported by the 2011 Specialzation Project
Research Grant funded by the Pusan National University.
References
[1] Jiao L, Li B, Wang M, Liu Z, Zhang X, Liu S. Antioxidant activities of the oli-
gosaccharides from the roots, ﬂowers and leaves of Panax ginseng C.A. Meyer.
Carbohydr Polym 2014;106:293e8.
[2] Song M, Kim B, Kim H. Inﬂuence of Panax ginseng on obesity and gut
microbiota in obese middle-aged Korean women. J Ginseng Res 2014;38:
106e15.
[3] Choi JH, Jin SW, Park BH, Kim HG, Khanal T, Han HJ, Hwang YP, Choi JM,
Chung YC, Hwang SK, et al. Cultivated ginseng inhibits 2,4-dinitro-
chlorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice
and TNF-alpha/IFN-gamma-induced TARC activation in HaCaT cells. Food
Chem Toxicol 2013;56:195e203.
[4] Gui Y, Ryu G. Effects of extrusion cooking on physicochemical properties of
white and red ginseng (powder). J Ginseng Res 2014;38:146e53.
[5] Zhang H, Li S, Zhang H, Wang Y, Zhao Z, Chen S, Xu H. Holistic quality
evaluation of commercial white and red ginseng using a UPLC-QTOF-MS/
MS-based metabolomics approach. J Pharm Biomed Anal 2012;62:258e73.[6] Jung MY, Jeon BS, Bock JY. Free, esteriﬁed, and insoluble-bound phenolic acids
in white and red Korean ginsengs (Panax ginseng C.A. Meyer). Food Chem
2002;79:105e11.
[7] Agarwal R, Gupta D. Severe asthma and fungi: current evidence. Med Mycol
2011;49:S150e7.
[8] Corrigan CJ, Kay AB. The roles of inﬂammatory cells in the pathogenesis of
asthma and of chronic obstructive pulmonary disease. Am J Resp Crit Care
Med 1991;143:1165e8.
[9] Corry DB. Emerging immune targets for the therapy of allergic asthma. Nat
Rev Drug Discov 2002;1:55e64.
[10] Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT,
Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, et al. Characterization
of the severe asthma phenotype by the National Heart, Lung, and Blood In-
stitute’s Severe Asthma Research Program. J Allergy Clin Immunol 2007;119:
405e13.
[11] Bielory L. Complementary and alternative interventions in asthma, allergy,
and immunology. Ann Allergy Asthma Immunol 2004;93:S45e54.
[12] Kim DY, Yang WM. Panax ginseng ameliorates airway inﬂammation in an
ovalbumin-sensitized mouse allergic asthma model. J Ethnopharmacol
2011;136:230e5.
[13] Mohi El-Din MM, Mostafa AM, Abd-Elkader A. Experimental studies on the
effect of (Lambda-Cyhalothrin) insecticide on lungs and the ameliorating ef-
fect of plant extracts (Ginseng (Panax Ginseng) and garlic (Allium sativum L.)
on asthma development in albino rats. BMC Res Notes 2014;7:243.
[14] Jung S, Cho SJ, Moon KI, Kim HW, Kim BY, Cho SI. Effects of Socheongryong-
Tang on immunoglobulin production in asthmatic mice. Kor J Herbol 2008;23:
23e8.
[15] Cho SJ, Kim HW, Kim BY, Cho SI. Sam So Eum, a herb extract, as the remedy for
allergen-induced asthma in mice. Pulm Pharmacol Ther 2008;21:578e83.
[16] Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG,
Gelfand EW. Noninvasive measurement of airway responsiveness in allergic
mice using barometric plethysmography. Am J Resp Crit Care 1997;156:
766e75.
[17] Chung Y, Cho J, Chang YS, Cho SH, Kang CY. Preventive and therapeutic effects
of oral tolerance in a murine model of asthma. Immunobiology 2002;206:
408e23.
C.-Y. Lim et al / Korean ginseng on OVA-induced asthma in mice 45[18] Kim JO, Kim DH, Chang WS, Hong C, Park SH, Kim S, Kang CY. Asthma is
induced by intranasal coadministration of allergen and natural killer T-cell
ligand in a mouse model. J Allergy Clin Immunol 2004;114:1332e8.
[19] Ramesh T, Kim S, Hwang S, Sohn S, Yoo S, Kim S. Panax ginseng reduces
oxidative stress and restores antioxidant capacity in aged rats. Nutr Res
2012;32:718e26.
[20] Ribeiro-Filho J, Calheiros AS, Vieira-de-Abreu A, de Carvalho KIM, da Silva
Mendes D, Melo CB, Martins MA, da Silva Dias C, Piuvezam MR, Bozza PT.
Curine inhibits eosinophil activation and airway hyper-responsiveness in
a mouse model of allergic asthma. Toxicol Appl Pharmacol 2013;273:19e
26.
[21] Thomas LH, Warner JA. The eosinophil and its role in asthma. Gen Pharmacol
Vasc S 1996;27:593e7.[22] Lauzon AM, Bates JH, Donovan G, Tawhai M, Sneyd J, Sanderson MJ. A multi-
scale approach to airway hyperresponsiveness: from molecule to organ. Front
Physiol 2012;3:191.
[23] Ong YE, Menzies-Gow A, Barkans J, Benyahia F, Ou TT, Ying S, Kay AB. Anti-IgE
(omalizumab) inhibits late-phase reactions and inﬂammatory cells after
repeat skin allergen challenge. J Allergy Clin Immunol 2005;116:558e64.
[24] Balzar S, Strand M, Rhodes D, Wenzel SE. IgE expression pattern in lung:
Relation to systemic IgE and asthma phenotypes. J Allergy Clin Immunol
2007;119:855e62.
[25] Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just Th2 cells.
Nat Rev Immunol 2010;10:838e48.
[26] Mazzarella G, Bianco A, Catena E, De Palma R, Abbate GF. Th1/Th2 lymphocyte
polarization in asthma. Allergy 2000;55:6e9.
